Alivus Life Sciences Ltd, based in India, is a pharmaceutical company that stands out with its certifications from FDA.
One of their notable products is RIVAROXABAN, with a corresponding US DMF Number 28864.
Remarkably, this DMF maintains an Active status since its submission on January 16, 2015, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of April 03, 2015, and payment made on January 16, 2015, indicating their dedication to facilitating drug approvals, Categorized as Type II